Results 161 to 170 of about 2,524,396 (364)

Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain: A Cerebral Organoid Study

open access: green, 2021
Cristiana Cruceanu   +20 more
openalex   +2 more sources

Neurotrophic-priming of glucocorticoid receptor signaling is essential for neuronal plasticity to stress and antidepressant treatment

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2015
Margarita Arango-Lievano   +5 more
semanticscholar   +1 more source

Challenges of modeling pristane‐induced lupus in non‐human primates

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Systemic lupus erythematosus (SLE) in cynomolgus monkeys was modeled by two intraperitoneal injections of pristane at a dose of 3.5 mL/kg, administered at weeks 1 and 23. Serum samples from all monkeys that received pristane tested positive for antinuclear antibodies.
Elena Vladimirovna Vinogradova   +5 more
wiley   +1 more source

The multimerization pathway of the glucocorticoid receptor. [PDF]

open access: yesNucleic Acids Res
Alegre-Martí A   +18 more
europepmc   +1 more source

Metal oxyanion stabilization of the rat glucocorticoid receptor is independent of thiols.

open access: hybrid, 1994
Kevin J. Modarress   +3 more
openalex   +1 more source

The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1 [PDF]

open access: gold, 2006
Kar Muthumani   +7 more
openalex   +1 more source

Targeting the glucocorticoid receptor in breast and prostate cancers

open access: yesScience Translational Medicine, 2015
Jacob Kach, S. Conzen, R. Szmulewitz
semanticscholar   +1 more source

Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders

open access: yesAnnals of Neurology, EarlyView.
Objective The objective of this study was to compare clinical features and prognosis of late‐onset neuromyelitis optica spectrum disorder (LO‐NMOSD, onset age ≥60 years) with adult‐onset NMOSD (AO‐NMOSD, onset age 18–59 years), and to provide insights for individualized management in elderly patients.
Ya‐Lan Pu   +15 more
wiley   +1 more source

Anti-Cancer Outcome of Glucocorticoid Receptor Transrepression by Synephrine Derivatives in Hematological Malignancies. [PDF]

open access: yesInt J Mol Sci
Zhidkova EM   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy